Inhibition of miR-200b Promotes Angiogenesis in Endothelial Cells by Activating The Notch Pathway

(Pages: 51-60)
Tie-Ying Qiu, M.M, 1Jin Huang, M.D, 1Li-Ping Wang, M.M, 1Bi-Song Zhu, M.D, 2,*
Clinical Nursing Teaching and Research Section of the Second Xiangya Hospital, Changsha 410011, P.R. China
Organ Transplant Center, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
Clinical Nursing Teaching and Research Section of the Second Xiangya Hospital, Changsha 410011, P.R. China
Organ Transplant Center, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
*Corresponding Address: Organ Transplant Center Xiangya Hospital Central South University Changsha 410008 P.R. China Email:277364307@qq.com
The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Qiu Tie-Ying, Huang Jin, Wang Li-Ping, Zhu Bi-Song. Inhibition of miR-200b Promotes Angiogenesis in Endothelial Cells by Activating The Notch Pathway. Cell J. 2021; 23(1): 51-60.

Abstract

Objective

Patients with diabetes mellitus frequently have chronic wounds or diabetic ulcers as a result of impaired wound healing, which may lead to limb amputation. Human umbilical vein endothelial cell (HUVEC) dysfunction also delays wound healing. Here, we investigated the mechanism of miR-200b in HUVECs under high glucose conditions and the potential of miR-200b as a therapeutic target.

Materials and Methods

In this experimental study, HUVECs were cultured with 5 or 30 mM glucose for 48 hours. Cell proliferation was evaluated by CCK-8 assays. Cell mobility was tested by wound healing and Transwell assays. Angiogenesis was analyzed in vitro Matrigel tube formation assays. Luciferase reporter assays were used to test the binding of miR-200b with Notch1.

Results

miR-200b expression was induced by high glucose treatment of HUVECs (P<0.01), and it significantly repressed cell proliferation, migration, and tube formation (P<0.05). Notch1 was directly targeted and repressed by miR-200b at both the mRNA and protein levels. Inhibition of miR-200b restored Notch1 expression (P<0.05) and reactivated the Notch pathway. The effects of miR-200b inhibition in HUVECs could be reversed by treatment with a Notch pathway inhibitor (P<0.05), indicating that the miR-200b/Notch axis modulates the proliferation, migration, and tube formation ability of HUVECs.

Conclusion

Inhibition of miR-200b activated the angiogenic ability of endothelial cells and promoted wound healing through reactivation of the Notch pathway in vitro. miR-200b could be a promising therapeutic target for treating HUVEC dysfunction.